Research ExplorerPublicationsTranscaval embolization for type II endoleak after endovascu...

Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm

Standard

Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm. / Heidemann, Franziska; Rohlffs, Fiona; Tsilimparis, Nikolaos; Spanos, Kostantinos; Behrendt, Christian-Alexander; Eleshra, Ahmed; Panuccio, Giuseppe; Debus, E Sebastian; Kölbel, Tilo.

In: J VASC SURG, Vol. 74, No. 1, 07.2021, p. 38-44.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Heidemann, F, Rohlffs, F, Tsilimparis, N, Spanos, K, Behrendt, C-A, Eleshra, A, Panuccio, G, Debus, ES & Kölbel, T 2021, 'Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm', J VASC SURG, vol. 74, no. 1, pp. 38-44. https://doi.org/10.1016/j.jvs.2020.12.067

APA

Heidemann, F., Rohlffs, F., Tsilimparis, N., Spanos, K., Behrendt, C-A., Eleshra, A., Panuccio, G., Debus, E. S., & Kölbel, T. (2021). Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm. J VASC SURG, 74(1), 38-44. https://doi.org/10.1016/j.jvs.2020.12.067

Vancouver

Heidemann F, Rohlffs F, Tsilimparis N, Spanos K, Behrendt C-A, Eleshra A et al. Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm. J VASC SURG. 2021 Jul;74(1):38-44. https://doi.org/10.1016/j.jvs.2020.12.067

Bibtex

@article{4cd308599cc24f1bbc1a46e7749354a4,
title = "Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm",
abstract = "OBJECTIVE: This study aims to determine the outcomes of transcaval embolization (TCE) for type II endoleak after infrarenal endovascular aortic repair (EVAR) and fenestrated/branched EVAR (F/BEVAR).METHODS: A retrospective single-center cohort study of all consecutive TCE procedures between August 2015 and August 2019 was performed to investigate technical success, in-hospital morbidity, and 30-day mortality as well as clinical success during follow-up. The indication for TCE was an aneurysm sac growth of 5 mm or more owing to a type II endoleak after EVAR for infrarenal or F/BEVAR for juxtarenal and type IV thoracoabdominal aortic aneurysm.RESULTS: A total 25 TCE procedures in 24 patients (95.8% male) were included. Technical success was 96.0% (24/25); selective and nonselective TCE were performed in 48% of patients. The in-hospital morbidity and 30-day mortality were 0%. The median follow-up was 23.1 months (interquartile range, 10.9-40.1 months). Freedom from type II endoleak-related reintervention was 84.6% at 12 months. Comparing clinical success after TCE, reintervention was necessary in 16.7% of patients after nonselective and 20% of patients after selective TCE. Regarding TCE after EVAR vs F/BEVAR, reintervention was performed in 12.5% of EVAR and 33.3% of F/BEVAR patients during follow-up.CONCLUSIONS: TCE is an acceptable treatment alternative for type II endoleak with aneurysm sac enlargement and can be used after EVAR for infrarenal abdominal aortic aneurysms and F/BEVAR for juxtarenal abdominal aortic aneurysms and type IV thoracoabdominal aortic aneurysms.",
keywords = "Aged, Aged, 80 and over, Aortic Aneurysm, Abdominal/diagnostic imaging, Aortic Aneurysm, Thoracic/diagnostic imaging, Blood Vessel Prosthesis Implantation/adverse effects, Embolization, Therapeutic/adverse effects, Endoleak/diagnostic imaging, Endovascular Procedures/adverse effects, Female, Humans, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Vena Cava, Inferior/diagnostic imaging",
author = "Franziska Heidemann and Fiona Rohlffs and Nikolaos Tsilimparis and Kostantinos Spanos and Christian-Alexander Behrendt and Ahmed Eleshra and Giuseppe Panuccio and Debus, {E Sebastian} and Tilo K{\"o}lbel",
note = "Copyright {\textcopyright} 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.",
year = "2021",
month = jul,
doi = "10.1016/j.jvs.2020.12.067",
language = "English",
volume = "74",
pages = "38--44",
journal = "J VASC SURG",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Transcaval embolization for type II endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type IV thoracoabdominal aortic aneurysm

AU - Heidemann, Franziska

AU - Rohlffs, Fiona

AU - Tsilimparis, Nikolaos

AU - Spanos, Kostantinos

AU - Behrendt, Christian-Alexander

AU - Eleshra, Ahmed

AU - Panuccio, Giuseppe

AU - Debus, E Sebastian

AU - Kölbel, Tilo

N1 - Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

PY - 2021/7

Y1 - 2021/7

N2 - OBJECTIVE: This study aims to determine the outcomes of transcaval embolization (TCE) for type II endoleak after infrarenal endovascular aortic repair (EVAR) and fenestrated/branched EVAR (F/BEVAR).METHODS: A retrospective single-center cohort study of all consecutive TCE procedures between August 2015 and August 2019 was performed to investigate technical success, in-hospital morbidity, and 30-day mortality as well as clinical success during follow-up. The indication for TCE was an aneurysm sac growth of 5 mm or more owing to a type II endoleak after EVAR for infrarenal or F/BEVAR for juxtarenal and type IV thoracoabdominal aortic aneurysm.RESULTS: A total 25 TCE procedures in 24 patients (95.8% male) were included. Technical success was 96.0% (24/25); selective and nonselective TCE were performed in 48% of patients. The in-hospital morbidity and 30-day mortality were 0%. The median follow-up was 23.1 months (interquartile range, 10.9-40.1 months). Freedom from type II endoleak-related reintervention was 84.6% at 12 months. Comparing clinical success after TCE, reintervention was necessary in 16.7% of patients after nonselective and 20% of patients after selective TCE. Regarding TCE after EVAR vs F/BEVAR, reintervention was performed in 12.5% of EVAR and 33.3% of F/BEVAR patients during follow-up.CONCLUSIONS: TCE is an acceptable treatment alternative for type II endoleak with aneurysm sac enlargement and can be used after EVAR for infrarenal abdominal aortic aneurysms and F/BEVAR for juxtarenal abdominal aortic aneurysms and type IV thoracoabdominal aortic aneurysms.

AB - OBJECTIVE: This study aims to determine the outcomes of transcaval embolization (TCE) for type II endoleak after infrarenal endovascular aortic repair (EVAR) and fenestrated/branched EVAR (F/BEVAR).METHODS: A retrospective single-center cohort study of all consecutive TCE procedures between August 2015 and August 2019 was performed to investigate technical success, in-hospital morbidity, and 30-day mortality as well as clinical success during follow-up. The indication for TCE was an aneurysm sac growth of 5 mm or more owing to a type II endoleak after EVAR for infrarenal or F/BEVAR for juxtarenal and type IV thoracoabdominal aortic aneurysm.RESULTS: A total 25 TCE procedures in 24 patients (95.8% male) were included. Technical success was 96.0% (24/25); selective and nonselective TCE were performed in 48% of patients. The in-hospital morbidity and 30-day mortality were 0%. The median follow-up was 23.1 months (interquartile range, 10.9-40.1 months). Freedom from type II endoleak-related reintervention was 84.6% at 12 months. Comparing clinical success after TCE, reintervention was necessary in 16.7% of patients after nonselective and 20% of patients after selective TCE. Regarding TCE after EVAR vs F/BEVAR, reintervention was performed in 12.5% of EVAR and 33.3% of F/BEVAR patients during follow-up.CONCLUSIONS: TCE is an acceptable treatment alternative for type II endoleak with aneurysm sac enlargement and can be used after EVAR for infrarenal abdominal aortic aneurysms and F/BEVAR for juxtarenal abdominal aortic aneurysms and type IV thoracoabdominal aortic aneurysms.

KW - Aged

KW - Aged, 80 and over

KW - Aortic Aneurysm, Abdominal/diagnostic imaging

KW - Aortic Aneurysm, Thoracic/diagnostic imaging

KW - Blood Vessel Prosthesis Implantation/adverse effects

KW - Embolization, Therapeutic/adverse effects

KW - Endoleak/diagnostic imaging

KW - Endovascular Procedures/adverse effects

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Retrospective Studies

KW - Time Factors

KW - Treatment Outcome

KW - Vena Cava, Inferior/diagnostic imaging

U2 - 10.1016/j.jvs.2020.12.067

DO - 10.1016/j.jvs.2020.12.067

M3 - SCORING: Journal article

C2 - 33348001

VL - 74

SP - 38

EP - 44

JO - J VASC SURG

JF - J VASC SURG

SN - 0741-5214

IS - 1

ER -